Literature DB >> 31078070

Oral mucosa and salivary findings in non-diabetic patients with chronic kidney disease.

Jovan Marinoski1, Marija Bokor-Bratic2, Igor Mitic3, Milos Cankovic4.   

Abstract

INTRODUCTION: Chronic kidney disease (CKD) and dialysis treatment could affect oral mucosa and cause qualitative or quantitative changes of saliva.
OBJECTIVE: The aim of the study was to investigate oral manifestations, unstimulated salivary flow rate (USFR), salivary pH value and biochemical composition of saliva in non-diabetic patients with CKD.
DESIGN: The study group (PD) consisted of 50 pre-dialysis patients diagnosed with CKD, positive control group (HD) of 25 haemodialysis patients and negative control (H) of 25 age and gender-matched healthy persons. Creatinine clearance rate (CrCl) was calculated from the blood creatinine using the Cockcroft-Gault formula. After a detailed intraoral examination, whole unstimulated saliva samples were collected to determine salivary pH value, and biochemical composition using a spectrophotometric method.
RESULTS: Statistical analysis revealed that PD subjects had more oral lesions (p < 0.05) and symptoms (p < 0.001) than controls. The mean CrCl was significantly lower (p < 0.05) in CKD subjects with pale mucosa, xerostomia, dysgeusia, and uremic odour, comparing to those without listed symptoms. PD subjects had significantly decreased USFR and increased pH, urea and creatinine than H controls (p < 0.05). A moderately strong positive correlation between serum and salivary creatinine in both PD (p < 0.05) and HD (p < 0.05) groups was found.
CONCLUSION: This study confirmed that xerostomia and dysgeusia are major symptoms among pre-dialysis patients. Their presence along with uremic odour and pale mucosa is directly related to decreased kidney function. On the diagnostic point, decreased USFR, especially hyposalivation and increased salivary creatinine, should be considered a significant indicator of CKD in stages before dialysis therapy.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chronic kidney disease; Creatinine; Oral mucosa; Saliva; Urea

Mesh:

Substances:

Year:  2019        PMID: 31078070     DOI: 10.1016/j.archoralbio.2019.04.021

Source DB:  PubMed          Journal:  Arch Oral Biol        ISSN: 0003-9969            Impact factor:   2.633


  4 in total

Review 1.  Salivary changes in chronic kidney disease and in patients undergoing hemodialysis: a systematic review and meta-analysis.

Authors:  Renata Prata Cunha Bernardes Rodrigues; Maria Tereza Campos Vidigal; Walbert A Vieira; Gustavo G Nascimento; Robinson Sabino-Silva; Cauane Blumenberg; Michelle F Siqueira; Walter L Siqueira; Luiz Renato Paranhos
Journal:  J Nephrol       Date:  2022-03-02       Impact factor: 4.393

2.  Correlations between the properties of saliva and metabolic syndrome: A prospective observational study.

Authors:  Daisuke Suzuki; Shin-Ichi Yamada; Akinari Sakurai; Imahito Karasawa; Eiji Kondo; Hironori Sakai; Hirokazu Tanaka; Tetsu Shimane; Hiroshi Kurita
Journal:  Medicine (Baltimore)       Date:  2020-12-18       Impact factor: 1.817

Review 3.  Oral health in patients with end-stage renal disease: A scoping review.

Authors:  Alexa Laheij; Wietse Rooijers; Lela Bidar; Lema Haidari; Aegida Neradova; Ralph de Vries; Frederik Rozema
Journal:  Clin Exp Dent Res       Date:  2021-08-29

4.  Bone turnover markers in serum but not in saliva correlate with bone mineral density.

Authors:  Katharina Kerschan-Schindl; Ewald Boschitsch; Rodrig Marculescu; Reinhard Gruber; Peter Pietschmann
Journal:  Sci Rep       Date:  2020-07-14       Impact factor: 4.996

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.